ANNX
Annexon, Inc.NASDAQHealthcare$5.50+2.61%ClosedMarket Cap: $657.8M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.25
P/S
0.00
EV/EBITDA
-2.61
DCF Value
$0.79
FCF Yield
-26.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-101.3%
ROA
-74.5%
ROIC
-91.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-50.3M | $-48.3M | $-0.26 | — |
| FY 2025 | $0.00 | NaN% | $-216.4M | $-206.7M | $-1.34 | — |
| Q3 2025 | $0.00 | NaN% | $-57.0M | $-54.9M | $-0.37 | — |
| Q2 2025 | $0.00 | NaN% | $-51.7M | $-49.2M | $-0.34 | — |
| Q1 2025 | $0.00 | NaN% | $-57.4M | $-54.4M | $-0.37 | — |
| Q4 2024 | $0.00 | NaN% | $-52.5M | $-48.6M | $-0.33 | — |
| FY 2024 | $0.00 | -Infinity% | $-154.1M | $-138.2M | $-1.01 | — |
| Q3 2024 | $0.00 | NaN% | $-39.4M | $-34.8M | $-0.25 | — |
| Q2 2024 | $0.00 | NaN% | $-33.6M | $-29.6M | $-0.23 | — |
| Q1 2024 | $0.00 | NaN% | $-28.6M | $-25.2M | $-0.21 | — |
| Q4 2023 | $0.00 | NaN% | $-30.0M | $-27.9M | $-0.36 | — |
| FY 2023 | $0.00 | NaN% | $-143.7M | $-134.2M | $-1.77 | — |